NEW YORK, NY, UNITED STATES, January 6, 2026 / EINPresswire.com / — Panther Life Sciences announces expanded access to its ...

Researchers at the University of California, Los Angeles (UCLA), in collaboration with pathologists from Hadassah Hebrew ...

Thanks to this tiny piece of tech, people with profound vision loss can now read, do cross word puzzles, and navigate public ...

Most pharmaceuticals sold today have their origin in a biochemistry laboratory. Drug discovery has traditionally started with a biochemical pathway implicated in a pathophysiological process. An ...

Illumina has recently advanced its plan to divest its cancer-diagnostics unit, a move intended to ease regulatory pressure and sharpen its focus on core DNA sequencing and microarray technologies.

Vaxxas Pty Ltd today announced the appointment of global biopharmaceutical executive Mr David Peacock as Chief Executive ...

Vaxxas has appointed former Merck Global Vaccines president David Peacock as chief executive officer (CEO), marking a step in ...

Brisbane-based Vaxxas has appointed David Peacock to lead the push to bring its vaccine patch technology to market.

Brisbane-based biotech company Vaxxas has appointed veteran pharmaceutical industry leader David Peacock as its new CEO as it moves to commercialise its needly free vaccination technology. Mr Peacock ...

One-step Library Prep Workflow Designed to Address the Scalability, Performance, and Affordability Needs of Applied ...

Following the installation of eProtein Discovery at leading academic institutes across the UK and Europe 1, the expansion ...

Well, a global provider of genomic library and multiplexing workflow solutions, today announced the launch of AgriPreptm Library Prep Kit, the newest addition to its next-generation TnXtm transposase ...